Provexis plc

0.85pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:PXSHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR 6.73%
Div yield —
ROE (75.26%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.67
PE TTM —
TSR TTM 48.18%
Mkt cap £20.06M
ROIC (47.86%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
1.06p
23.81%
29.98%
Hold 12|6|6|6|12
3Q26
4Q26
1Q27
2Q27
Earnings per share£
0.02
0.02
0.02
0.03
17.10%
8.55%
26.08%
30.34%
Revenue£M
2.787
2.937
2.931
2.998
9.89%
10.46%
7.53%
9.21%
Peers (US$29.20M)
Cap (US$)
PE
76.13M
26.51x
Capital
TTM
5Y
10Y
Leveragex
0.856
(0.148)
(0.164)
EBIT/Intx
0.479
1.047
1.029
Own earn%
(9.57)
(62.52)
(62.60)
Sh yield%
17.64
31.34
30.05
Owners
Insiders/Inst%
8.95
88.03
Short interest%
3.40
SBC / revenue%
4.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
23–26
$1 testx
0.5
Incr. ROIC%
−4